Mark Rosenthal
- Pulmonary and Respiratory Medicine top 0.2%
- Brain Metastases and Treatment 30
- Prostate Cancer Treatment and Research 25
- Lung Cancer Treatments and Mutations 11
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 69
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 15
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 19
-
- Radiomics and Machine Learning in Medical Imaging 16
-
- Neuroblastoma Research and Treatments 13
- Co-authors
- Ian F. TannockMario A. EisenbergerRonald de WitKim N.Christine ThéodoreNicholas D. JamesIngela TuressonA Płużańska
- Journals
- Journal of Clinical Oncology (23 papers)Neuro-Oncology (15 papers)Annals of Oncology (6 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Rosenthal
198 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Pulmonary and Respiratory Medicine 5.9k
- Genetics 1.5k
- Cancer Research 1.8k
- Oncology 2.7k
- Radiology, Nuclear Medicine and Imaging 1.7k
Countries citing papers authored by Mark Rosenthal
This map shows the geographic impact of Mark Rosenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rosenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rosenthal more than expected).
Fields of papers citing papers by Mark Rosenthal
This network shows the impact of papers produced by Mark Rosenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rosenthal. The network helps show where Mark Rosenthal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Rosenthal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 2 | |
| 6 | A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY | 2019 | 1 |
| 7 | 2019 | 4 | |
| 8 | ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer | 2018 | 1 |
| 9 | 2017 | 10 | |
| 10 | BRAIN TUMOURS: SUCCESSES AND CHALLENGES ON THE OTHER SIDE OF THE BLOOD-BRAIN BARRIER | 2015 | 0 |
| 11 | Gliomabreakdown → | 2015 | 792 |
| 12 | 2013 | 8 | |
| 13 | 2012 | 64 | |
| 14 | 2009 | 42 | |
| 15 | Imatinib plus hydroxyurea versus hydroxyurea monotherapy in progressive glioblastoma (GBM) - An international open label randomised phase III study (ambrosia-study) | 2007 | 2 |
| 16 | The development of hyaluronic acid as a targeted transport vehicle for chemotherapeutic drugs | 2005 | 2 |
| 17 | 2005 | 247 | |
| 18 | 2004 | 27 | |
| 19 | 2002 | 47 | |
| 20 | 1992 | 17 |
About Mark Rosenthal
Mark Rosenthal is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 206 papers that have together received 10.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (69 papers), Brain Metastases and Treatment (30 papers), Prostate Cancer Treatment and Research (25 papers), Cancer Treatment and Pharmacology (19 papers), Radiomics and Machine Learning in Medical Imaging (16 papers), Cancer Genomics and Diagnostics (15 papers), Neuroblastoma Research and Treatments (13 papers) and Lung Cancer Treatments and Mutations (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.9k citations), Genetics (1.5k citations) and Cancer Research (1.8k citations). Mark Rosenthal has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Ian F. Tannock, Mario A. Eisenberger, Ronald de Wit, Kim N., Christine Théodore, Nicholas D. James, Ingela Turesson, A Płużańska, J Horti and William R. Berry. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Annals of Oncology, The Medical Journal of Australia and The Art Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.